Search

Your search keyword '"Rubin, Mark A"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Rubin, Mark A" Remove constraint Author: "Rubin, Mark A" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
96 results on '"Rubin, Mark A"'

Search Results

2. Pathway and network analysis of more than 2500 whole cancer genomes

3. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

4. Alterations in homologous recombination repair genes in prostate cancer brain metastases

6. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

7. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

8. G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer

10. Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia

12. Patient-derived xenografts and organoids model therapy response in prostate cancer

14. Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer

16. Molekularpathologie bei urologischen Tumoren

19. Common germline-somatic variant interactions in advanced urothelial cancer

20. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

21. A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance

23. Fusions involving BCOR and CREBBP are rare events in infiltrating glioma

24. Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

25. Loneliness and Ethnic Composition of the School Class: A Nationally Random Sample of Adolescents

27. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

28. NSD2 is a conserved driver of metastatic prostate cancer progression

29. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

30. Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

32. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

33. Patient derived organoids to model rare prostate cancer phenotypes

34. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics

35. Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4

36. Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network

37. Inherited determinants of early recurrent somatic mutations in prostate cancer

40. Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations

41. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer

43. Clonal evolution of chemotherapy-resistant urothelial carcinoma

44. Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care

45. Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity

46. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

49. MAGI3–AKT3 fusion in breast cancer amended

Catalog

Books, media, physical & digital resources